KAS
BMRN icon

Kestra Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Kestra Advisory Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,754
Closed -$686K – 2672
2024
Q3 		$686K Buy
9,754
+620
+7% +$51.8K ﹤0.01% 1558
2024
Q2 		$752K Sell
9,134
-9,251
-50% -$770K ﹤0.01% 1500
2024
Q1 		$1.61M Buy
18,385
+3,095
+20% +$277K 0.01% 984
2023
Q4 		$1.47M Buy
15,290
+1,456
+11% +$129K 0.01% 949
2023
Q3 		$1.22M Buy
13,834
+2,817
+26% +$251K 0.01% 902
2023
Q2 		$955K Buy
11,017
+712
+7% +$67K 0.01% 1002
2023
Q1 		$1M Buy
10,305
+558
+6% +$57.8K 0.01% 947
2022
Q4 		$1.01M Buy
9,747
+3,001
+44% +$282K 0.01% 1053
2022
Q3 		$572K Buy
6,746
+449
+7% +$40K 0.01% 1243
2022
Q2 		$522K Sell
6,297
-1,714
-21% -$136K 0.01% 1308
2022
Q1 		$618K Buy
8,011
+4,277
+115% +$358K 0.01% 1172
2021
Q4 		$330K Sell
3,734
-237
-6% -$19.6K ﹤0.01% 1547
2021
Q3 		$307K Buy
3,971
+300
+8% +$23.7K ﹤0.01% 1652
2021
Q2 		$306K Buy
3,671
+408
+13% +$32.3K ﹤0.01% 1552
2021
Q1 		$246K Buy
+3,263
New +$267K ﹤0.01% 1590

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Kestra Advisory Services's BMRN Position: Q4 2024 in Review

Kestra Advisory Services sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2024, closing a stake of 9,754 shares — an estimated $686K sold.

Kestra Advisory Services first reported a position in BMRN in Q1 2021 and held it in 15 quarters. The position peaked at $1.61M in Q1 2024. 543 funds tracked by Wall St. Rank hold BMRN as of Q4 2024.

  • Kestra Advisory Services reported no remaining BioMarin Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 9,754 BioMarin Pharmaceuticals shares in Q4 2024, an estimated $686K.
  • Kestra Advisory Services first reported a position in BioMarin Pharmaceuticals in Q1 2021 and held it in 15 quarters.
  • Kestra Advisory Services's BioMarin Pharmaceuticals position peaked at $1.61M in Q1 2024.
  • 543 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2024.

Based on Kestra Advisory Services's 13F filing for Q4 2024, filed 10 Feb 2025.